A detailed history of Inverness Counsel LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Inverness Counsel LLC holds 166,447 shares of ZTS stock, worth $31.8 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
166,447
Previous 134,915 23.37%
Holding current value
$31.8 Million
Previous $23.2 Million 6.43%
% of portfolio
1.37%
Previous 1.3%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

BUY
$148.29 - $182.55 $4.68 Million - $5.76 Million
31,532 Added 23.37%
166,447 $24.7 Million
Q2 2022

Jul 20, 2022

SELL
$155.97 - $200.09 $1.09 Million - $1.4 Million
-7,007 Reduced 4.94%
134,915 $23.2 Million
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $7.97 Million - $10.3 Million
-43,922 Reduced 23.63%
141,922 $26.8 Million
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $3.54 Million - $4.52 Million
-18,300 Reduced 8.96%
185,844 $45.4 Million
Q3 2021

Nov 02, 2021

SELL
$189.29 - $209.69 $21.3 Million - $23.6 Million
-112,510 Reduced 35.53%
204,144 $39.6 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $4.42 Million - $5.33 Million
28,342 Added 9.83%
316,654 $59 Million
Q1 2021

May 04, 2021

SELL
$144.0 - $169.39 $121,104 - $142,456
-841 Reduced 0.29%
288,312 $45.4 Million
Q4 2020

Jan 27, 2021

SELL
$157.07 - $174.35 $7.36 Million - $8.17 Million
-46,850 Reduced 13.94%
289,153 $47.9 Million
Q3 2020

Nov 03, 2020

SELL
$137.1 - $165.37 $216,618 - $261,284
-1,580 Reduced 0.47%
336,003 $55.6 Million
Q2 2020

Aug 10, 2020

SELL
$111.92 - $142.53 $5.62 Million - $7.16 Million
-50,210 Reduced 12.95%
337,583 $46.3 Million
Q1 2020

May 05, 2020

BUY
$92.66 - $144.94 $1.85 Million - $2.89 Million
19,951 Added 5.42%
387,793 $45.6 Million
Q4 2019

Feb 05, 2020

SELL
$116.25 - $133.25 $9.67 Million - $11.1 Million
-83,168 Reduced 18.44%
367,842 $48.7 Million
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $85,440 - $97,478
759 Added 0.17%
451,010 $56.2 Million
Q2 2019

Aug 07, 2019

SELL
$97.98 - $114.28 $3.43 Million - $4 Million
-34,967 Reduced 7.21%
450,251 $51.1 Million
Q1 2019

May 09, 2019

SELL
$81.56 - $100.67 $137,265 - $169,427
-1,683 Reduced 0.35%
485,218 $48.8 Million
Q4 2018

Jan 29, 2019

BUY
$79.28 - $95.27 $2.36 Million - $2.83 Million
29,755 Added 6.51%
486,901 $41.6 Million
Q3 2018

Oct 30, 2018

SELL
$83.5 - $93.23 $6.44 Million - $7.19 Million
-77,129 Reduced 14.44%
457,146 $41.9 Million
Q2 2018

Aug 02, 2018

BUY
$79.9 - $89.2 $7.66 Million - $8.56 Million
95,915 Added 21.88%
534,275 $45.5 Million
Q1 2018

May 02, 2018

BUY
$71.51 - $84.69 $70,079 - $82,996
980 Added 0.22%
438,360 $36.6 Million
Q4 2017

Feb 02, 2018

BUY
$63.24 - $72.8 $3.86 Million - $4.44 Million
61,035 Added 16.22%
437,380 $31.5 Million
Q3 2017

Oct 17, 2017

BUY
$59.73 - $65.4 $22.5 Million - $24.6 Million
376,345
376,345 $24 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $89.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.